Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes

Figure 1

The characteristics of clusters 1 and 2. (a) Correlation between immune checkpoint-related gene expression and clinical characteristics in two clusters. (b) Survival analysis of clusters 1 and 2. (c) PCA analysis of clusters 1 and 2. (d) Comparison of the distribution of immune cells in clusters 1 and 2.

(a)

(b)

(c)

(d)